Cantor picks 14 undervalued biotech stocks worth a second look

view original post

Cantor Fitzgerald has selected its 14 top picks for biotech stocks that it regards as significantly undervalued and worth a “fresh” look. All of the picks were down more than 20% year-to-date, as of …